Paul Capital provides creative liquidity solutions for direct investments.
Paul Capital was formed in 1991 as a pioneer in the secondary market, providing creative liquidity solutions to investors in private equity limited partnerships and portfolios of direct investments. In 1999, Paul Capital added its Healthcare Platform to invest in royalty and revenue interests in life science products. Today, Paul Capital sees the world from the vantage point of an experienced investor with unique insight and the ability to build compelling solutions for institutional investors. The team has grown to nearly 100 employees, with offices in Hong Kong, London, New York, Paris, San Francisco and São Paulo, managing a total of more than $6 billion across its distinct investment platforms.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 22, 2009
UCB
|
Post-IPO Equity | $100M | Biotechnology | Yes |
Apr 6, 2000
eVentures Group
|
Series Unknown | $58.50M | Internet | — |